I am a senior associate in the Intellectual Property Group in London, with a focus on regulatory and commercial matters primarily in the life sciences and healthcare sectors.
Having a keen interest in all things life sciences and healthcare, I specialise primarily in providing regulatory and commercial advice in relation to a broad range of matters in these sectors. My experience includes advising on the regulation of pharmaceuticals, medical devices, general healthcare services, clinical trials, marketing and advertising of health products, borderline products, food and beverages (including food supplements and novel foods), cosmetic products, and legislative drafting in the healthcare context. A recent focus area is advising on all aspects relating to digital health, including software as medical device, the impact of AI, and telemedicine.
As a member of the firm's Product Compliance and Liability Group, I further advise on various product compliance matters relating to a wide variety of manufactured products being placed on the UK and EU markets, including CE/UKCA marking, RoHS, WEEE, EMC, REACH, and various other product compliance regulations. I further provide regulatory advice on sustainability-related matters such as extended producer responsibility (EPR) and waste management. The implications of Brexit-related changes to the UK regulatory regimes applicable to an extensive range of product compliance regulations (including those applicable to health products) remain a significant area of interest.
My practice further includes commercial work, including supporting corporate transactions and the drafting of a wide range of general and bespoke agreements in the life sciences and healthcare sectors, including transactional IP work such as licensing deals and collaborations.
I contribute to leading publications, and I am a co-author of the 'Guide to EU and UK Pharmaceutical Regulatory Law' (Kluwer Law International), which is written entirely by the Bird & Bird team across Europe.